Perioperative Coagulopathy, Bleeding, and Hemostasis During Cardiac Surgery
ICU Director · 2010
DOI: 10.1177/1944451609357759 ↗Kurz gefasst
Fachartikel in der Zeitschrift ICU Director, 2010. Verfasst von Moody Makar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Cardiac surgery patients use 10%-25% of the blood products transfused annually in the United States. The transfusion of red blood cells or blood products has been the subject of intense scrutiny over the past 10 years. Bleeding after cardiac surgery can be surgical or nonsurgical and lead to hemodynamic compromise and surgical reexploration. Because hemorrhage and blood product transfusions are associated with multiple negative outcomes, including increased mortality, it is prudent to understand the mechanisms responsible for nonsurgical bleeding. This review focuses on the physiology of the normal coagulation and fibrinolysis, risk factors associated with patients presenting for cardiac surgery, impairments of normal hemostasis associated with cardiac surgery and cardiopulmonary bypass (CPB), and potential interventions to reduce perioperative blood loss and blood transfusion.
Zitieren
APA
Makar, M., Taylor, J., Zhao, M., Farrohi, A., Trimming, M., & D’Attellis, N. (2010). Perioperative Coagulopathy, Bleeding, and Hemostasis During Cardiac Surgery. ICU Director. https://doi.org/10.1177/1944451609357759
Vancouver
Makar M, Taylor J, Zhao M, Farrohi A, Trimming M, D’Attellis N. Perioperative Coagulopathy, Bleeding, and Hemostasis During Cardiac Surgery. ICU Director. 2010. doi:10.1177/1944451609357759
BibTeX
@article{Makar2010,
author = {Makar, Moody and Taylor, Jamie and Zhao, Maxnu and Farrohi, Ali and Trimming, Michael and D’Attellis, Nicola},
title = {Perioperative Coagulopathy, Bleeding, and Hemostasis During Cardiac Surgery},
journal = {ICU Director},
year = {2010},
doi = {10.1177/1944451609357759}
}
EUVIMED